Cervical Squamous Cell Carcinoma — Trials

Cervical Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 44%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 16.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03074513	Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors	active not recruiting	Phase 2	133	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026	clinicaltrials
NCT04580771	A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial	active not recruiting	Phase 2	22	M.D. Anderson Cancer CenterOTHER	1	Apr 15, 2026	clinicaltrials